Argeris Karabelas

Chief Executive Officer at Clinical Development Capital LLC

Argeris Karabelas

Argeris Karabelas

Chief Executive Officer at Clinical Development Capital LLC

Overview
Career Highlights

NitroMed, Inc.
Clinical Development Capital LLC
CIBA Vision Corp.

RelSci Relationships

2320

Number of Boards

30

Birthday

1953

Age

66

Contact Data
Trying to get in touch with Argeris Karabelas? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Argeris Karabelas likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Care Capital LLC

Relationship likelihood: Strong

Co-Founder at Purfoods LLC

Relationship likelihood: Strong

Chairman of the Board & Chief Executive Officer at Bausch Health Cos., Inc.

Relationship likelihood: Strong

Chief Financial Officer at Care Capital LLC

Relationship likelihood: Strong

Clinical Professor, Department of Psychiatry at Georgetown University - School of Medicine

Relationship likelihood: Strong

Chairman at Vaxart, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Palladio Biosciences, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Chief Physician at The Brigham & Women's Hospital, Inc.

Relationship likelihood: Strong

Chairman at Sapience Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Argeris Karabelas
Potential Connections via
Relationship Science
You
Argeris Karabelas
Chief Executive Officer at Clinical Development Capital LLC
Education
B.S. in Biochemistry

UNH is a vibrant place: a land-, sea-, and space-grant university located in Durham, N.H., Concord, N.H. and Manchester, NH.

Ph.D. in Pharmaceutical Sciences & Pharmacokinetics

Mission Statement:Massachusetts College of Pharmacy and Health Sciences provides a unique academic environment to guide and support students toward successful, sustainable careers and leadership in health care. As a private independent institution with a long and distinguished history of specializing in health sciences education, the College offers traditional and non-traditional programs that embody teaching excellence, active scholarship and research, professional service, and community outreach.

Ph.D Pharmacokinetics

Massachusetts College of Liberal Arts is a school in North Adams.

Career History
Chief Executive Officer
Current

Clinical Development Capital LLC (CDC) provides funding for ethical drug clinical trials in return for contingent milestone payments and drug royalties. The company is headquartered in Princeton, NJ

Chairman-Worldwide Pharmaceuticals
1997 - 2000

Novartis Pharma Schweiz AG researches and develops vaccines for viral diseases. The firm provides vaccines and conventional products to combat viral and bacterial diseases across the globe. The company was founded in 1996 and is headquartered in Rotkreuz, Switzerland.

Founder
2000 - 2001

Novartis Bioventure Fund focuses on companies operating in the field of life science technology. The geographical focus includes the US, Canada, UK and Switzerland. The fund invests in biotechnology, pharmaceuticals and medical device products. It invests in all stages of financing and also invests in mezzanine transactions.

Boards & Committees
Independent Director
2016 - Current

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Independent Member, Board of Directors
2015 - Current

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Chairman
Current

Care Capital focuses on investments in later-stage biotechnology and specialty pharmaceutical companies. The firm looks for companies that are developing pharmaceutical assets and whose lead products have reached late-preclinical or early clinical development. Initial investments typically range from $5 million to $20 million. Care Capital participates in a variety of types of investments including growth capital and acquisitions of private, corporate-owned or public companies.

Director
Prior

The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA.

Trustee
Prior

University of the Sciences, are building on a life sciences legacy started almost two centuries ago as Philadelphia College of Pharmacy. From treating, researching and studying diseases and cures on a molecular level to the medicines that improve the lives of people worldwide, USciences is about moving life forward. The University has launched the careers of many innovative and pioneering individuals in the field of healthcare. The University is accredited by the Commission on Higher Education of the Middle States Association of Colleges and Schools.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$5,000 +
2010

The UNH Foundation was established in 1989 to build private support for the University of New Hampshire.

N/A
2009

The UNH Foundation was established in 1989 to build private support for the University of New Hampshire.

Political Donations
$500
2012

Senator at Office of the Senator from Utah, Mitt Romney

$2,500
2011

Former Governor of Utah

$1,000
2010

Former Senator from New Hampshire

Investments
Details Hidden

Thrive Bioscience, Inc. develops advance drug discovery solutions. The firm provides automated non-microbial cell culture instruments for research, drug discovery, drug development and regenerative medicine markets. The company was founded by Alan P. Blanchard and Thomas Forest Farb in 2014 and is headquartered in Wakefield, MA.

Details Hidden

Somnus Therapeutics, Inc. operates as a pharmaceutical company. It develops therapeutics to address the need of insomnia patients. The company was founded by Gary C. Cupit in June 2007 is headquartered in Branchburg, NJ.

Details Hidden

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Argeris Karabelas. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Argeris Karabelas's profile does not indicate a business or promotional relationship of any kind between RelSci and Argeris Karabelas.